Sage Therapeutics, Inc.

SAGEDelisted Jul 31, 2025

Industry: Pharmaceutical Preparations
SEC CIK: 0001597553

SEC filings (opens in a new tab)

Sage Therapeutics, Inc. was delisted on Jul 31, 2025; its insiders filed their last Form 4 on Jul 31, 2025; 192 institutions reported holding it in 13F filings for Q2 2025, worth $445.6M in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding Sage Therapeutics, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022 All holders in Q3 2022

13F holders of SAGE: Q3 2022 compared with Q4 2022
Measure	Q3 2022	Of which not filed for Q4 2022	Q4 2022	Change
Holders	201	3	207	+9
Shares	51.5M	9.81K	51.6M	+183.7K (+0.4%)
Value	$2.02B	$384.2K	$1.97B	−$45.8M (−2.3%)

3 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held Sage Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to SAGE in Q4 2022
Institution	Shares	Value	% of portfolio
Camber Capital Management LP	700,000	$26.7M	0.93%
Saturn V Capital Management LLC	156,085	$5.37M	4.45%
Jane Street Group, LLC	89,602	$3.42M	0.01%
Schroder Investment Management Group	57,386	$2.19M	0.00%
Ergoteles LLC	50,067	$1.91M	0.07%
Altium Capital Management LP	50,000	$1.91M	0.98%
Jupiter Asset Management Ltd	40,137	$1.53M	0.02%
Cambridge Investment Research Advisors, Inc.	36,431	$1.39M	0.01%
Fox Run Management, L.L.C.	17,148	$654.0K	0.26%
Jefferies Financial Group Inc.	13,750	$524.4K	0.01%
Arete Wealth Advisors, LLC	4,268	$473.4K	0.04%
Pendal Group Limited	8,702	$331.9K	0.00%
Roundview Capital LLC	8,260	$315.0K	0.04%
Y-Intercept (Hong Kong) Ltd	8,050	$307.0K	0.05%
Qube Research & Technologies Ltd	7,953	$303.3K	0.00%
Marex Group plc	7,713	$294.2K	0.04%
Pictet Asset Management SA	6,538	$249.0K	0.00%
Raymond James & Associates	6,305	$240.5K	0.00%
Neo Ivy Capital Management	5,094	$194.0K	0.13%
PEAK6 Investments LLC	3,145	$120.0K	0.01%
Advisory Services Network, LLC	3,010	$114.8K	0.00%
New England Capital Financial Advisors LLC	134	$5.70K	0.00%
Cary Street Partner Investment Advisory LLC	70	$2.67K	0.00%
Larson Financial Group LLC	59	$2.25K	0.00%
Comerica Securities,inc.	40	$1.53K	0.00%
Baker Avenue Asset Management, LP	12	$458	0.00%
McElhenny Sheffield Capital Management, LLC	8	$305	0.00%
AdvisorNet Financial, Inc	4	$153	0.00%
GWM Advisors LLC	100	$4	0.00%
Private Trust Co NA	4	$0	0.00%
Steward Financial Group LLC	7	$0	0.00%

Sold out (22)

Institutions that held Sage Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of SAGE in Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
Point72 Asset Management, L.P.	801,600	$31.4M
Sector Gamma AS	115,696	$4.53M
Diametric Capital, LP	34,515	$1.35M
Balyasny Asset Management LLC	33,794	$1.32M
Tudor Investment Corp Et Al	17,207	$674.0K
Gsa Capital Partners LLP	13,557	$531.0K
Renaissance Technologies LLC	12,700	$497.0K
Guggenheim Capital LLC	11,674	$457.0K
Man Group plc	9,053	$355.0K
SEI Investments Co	8,207	$321.0K
Parallax Volatility Advisers, L.P.	7,386	$289.0K
Bayesian Capital Management, LP	6,800	$266.0K
Aquatic Capital Management LLC	6,400	$251.0K
STRS Ohio	4,700	$184.0K
Macquarie Group Ltd	2,637	$139.0K
Amundi	2,758	$114.0K
HighMark Wealth Management LLC	500	$20.0K
High Net Worth Advisory Group LLC	100	$4.00K
Meeder Asset Management Inc	33	$1.00K
Dark Forest Capital Management LP	21	$1.00K
Beaird Harris Wealth Management, LLC	25	$1.00K
Quent Capital, LLC	21	$1.00K

Not filed for Q4 2022 yet (3)

Institutions that held Sage Therapeutics, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SAGE in Q3 2022 that haven't filed for Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
Jefferies Group LLC	9,250	$362.2K
Wipfli Financial Advisors LLC,	422	$17.0K
FourThought Financial, LLC	138	$5.00K